The kit is based on real-time RT-PCR technology, for the qualitative detection of SARS-CoV-2 specific RNA. The assay includes a positive control and an internal control.
The global market for Novel Coronavirus Nucleic Acid Detection Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Novel Coronavirus Nucleic Acid Detection Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Novel Coronavirus Nucleic Acid Detection Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Novel Coronavirus Nucleic Acid Detection Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Novel Coronavirus Nucleic Acid Detection Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Novel Coronavirus Nucleic Acid Detection Kit players cover Abbott, ID SOLUTIONS, altona Diagnostics, GeneProof and Roche Diagnostics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Novel Coronavirus Nucleic Acid Detection Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Novel Coronavirus Nucleic Acid Detection Kit market, with both quantitative and qualitative data, to help readers understand how the Novel Coronavirus Nucleic Acid Detection Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Novel Coronavirus Nucleic Acid Detection Kit market and forecasts the market size by Type (Pharyngeal Swab, Nasal Swab and Other), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Pharyngeal Swab
Nasal Swab
Other
Segmentation by application
Hospital
Clinic
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
ID SOLUTIONS
altona Diagnostics
GeneProof
Roche Diagnostics
Aurora
3B BlackBio Biotech India Limited
CerTest Biotec, SL
Hologic
Biogerm Medical
GeneoDx Biotech
Liferiver
Mole Bioscience
Bioperfectus
Rendu Biotechnology
Applied Biological
Sansure Biotech
Guangodng Hecin Scientific, Inc.
TransGen Biotech
Coyote Bioscience
Daan Gene
Orient Gene
Nanjing Synthgene Medical Technology
Shenzhen Uni-medica Technology
Hybribio
BGI Group
Chapter Introduction
Chapter 1: Scope of Novel Coronavirus Nucleic Acid Detection Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global Novel Coronavirus Nucleic Acid Detection Kit market size (sales and revenue) and CAGR, Novel Coronavirus Nucleic Acid Detection Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Novel Coronavirus Nucleic Acid Detection Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Novel Coronavirus Nucleic Acid Detection Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Novel Coronavirus Nucleic Acid Detection Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, ID SOLUTIONS, altona Diagnostics, GeneProof, Roche Diagnostics, Aurora, 3B BlackBio Biotech India Limited, CerTest Biotec, SL and Hologic, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Novel Coronavirus Nucleic Acid Detection Kit. Industry analysis & Market Report on Novel Coronavirus Nucleic Acid Detection Kit is a syndicated market report, published as Global Novel Coronavirus Nucleic Acid Detection Kit Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Novel Coronavirus Nucleic Acid Detection Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.